Item 3. Quantitative and Qualitative Disclosures about Market Risk

0K characters. Original on sec.gov · Markdown

Item 3. Quantitative and Qualitative Disclosures about Market Risk

For quantitative and qualitative disclosures about market risk affecting Teradyne, see Part 2 Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” in our Annual Report on Form 10-K filed with the SEC on February 19, 2026. There were no material changes in our exposure to market risk from those set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

Previous: Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations · Next: Item 4. Controls and Procedures